Daily news - 19.11.2018
Published: 19. 11. 2018

SLOVENIA

Gea to be delisted after small shareholders squeezed out

Tovarna Olja Gea, the biggest producer of edible oils in Slovenia, will be delisted from the Ljubljana Stock Exchange after the majority shareholder squeezed out the remaining small shareholders on Friday.
Source: STA

Schenker Slovenia ups revenue, profit in 2017

The Slovenian arm of the German DB Schenker logistics group generated EUR 45.62m in sales revenue last year, 19% more than in 2016. Its net profit grew by 9% to EUR 3.39m, according to the company's business report available on the website of the Agency for Public Legal Records (AJPES).
Source: STA

INTERNATIONAL MARKETS

Stocks post steep weekly losses as Facebook, Amazon and Apple shares struggle; European markets close mildly lower as sterling stabilizes after Brexit drama

Stocks posted sharp weekly losses on Friday after a strong downturn in technology shares. The S&P 500 fell 1.6 percent this week, while the Dow Jones Industrial Average and Nasdaq Composite both declined more than 2 percent. Technology, the biggest sector in the S&P 500 by market cap, was the second-worst performer this week, falling 2.5 percent. The sector dropped following a 5.4 percent decline in Apple. Wall Street analysts worry iPhone sales will slow down. Tech was under pressure again on Friday as shares of Nvidia plunged 18.8 percent on disappointing revenue and guidance. European stocks were lower Friday afternoon, as investors continued to closely monitor the ongoing political turmoil in the U.K. The pan-European Stoxx 600 finished down around 0.12 percent during Friday deals. On the week the European list of blue chips shed 2.68 percent. Europe's banking index suffered more losses Friday, down around 0.74 percent as U.K. lenders struggled amid heightened fears the country could soon crash out of the European Union without a Brexit divorce deal. Metro Bank, Lloyds and RBS all shed value. Elsewhere, Astrazeneca said Friday that the combination of two immunotherapy drugs did not meet the main goal in a closely watched late-stage study for a certain type of lung cancer, Reuters reported. Shares of the company fell 1.79 percent.
Source: CNBC

SERBIA

NBS: Mid-term inflation expected in a range of 2.5-3%

According to the latest NBS inflation survey, annual inflation in Serbia, for one year ahead period, is expected in a range of 2.4-2.8%. The same report says that mid-term inflation (two years ahead) is expected in a range of 2.5%-3.0%.
Source: NBS, Ilirika

NBS has increased GDP growth projection to 4.2%

The National Bank of Serbia (NBS) has increased its projection of Serbia's GDP growth from 4.0% to 4.2%, NBS Vice-Governor Zeljko Jovic announced Friday. Since the beginning of the year, Serbia has registered the fastest growth in the past ten years, and it was at 4.5% over the past three quarters, Jovic said at the presentation of the November Inflation Report.
Source: Tanjug

Serbia receives EUR 200 million in credits for investments in health infrastructure

The Council of Europe Development Bank (CEB) lent nearly EUR 1.1 billion for new social projects in 11 European countries, with Serbia receiving the highest amount, on Friday, November 16. CEB has set aside EUR 200 million for Serbia for investments in health infrastructure, says the statement sent to Tanjug.
Source: Ekapija